Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
FOMX was delisted on the 6th of March, 2020.
56 hedge funds and large institutions have $108M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 23 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less capital invested
Capital invested by funds: $117M → $108M (-$9.74M)
15% less funds holding
Funds holding: 66 → 56 (-10)
22% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 18
39% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$5.28M |
| 2 |
DM
Deerfield Management
New York
|
+$2.21M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.82M |
| 4 |
NC
Nexthera Capital
New York
|
+$964K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$697K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Senzar Asset Management
New York
|
-$6.64M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$3.96M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.91M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$1.34M |
| 5 |
JP Morgan Chase
New York
|
-$1.23M |
FOMX Hedge Fund Activity: Q2 2016 in Review
56 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q2 2016, worth a combined $108M — down 8.3% from $117M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of FOMX and 14 opened new positions — a net loss of 9 holders — while 18 trimmed existing stakes and 14 added.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $5.28M. The largest seller was Senzar Asset Management, cutting an estimated $6.64M.
- 56 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q2 2016, down from 66 in Q1 2016.
- Funds reported $108M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q2 2016, down 8.3% quarter-over-quarter.
- 14 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q2 2016 and 23 closed out, a net change of -9 holders.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q2 2016 was Perceptive Advisors, an estimated $5.28M added.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q2 2016 was Senzar Asset Management, an estimated $6.64M sold.
Based on aggregated 13F filings for Q2 2016.